|
Corey Dambacher
|
| Title: |
Founder and CEO |
| Industry: |
Consulting |
| Type of Organization: |
Consultancy |
| Major Product/Service: |
Provides consulting services to provide ideas for companies to practice for commercialization within expanding biotechnology markets |
| Expertise: |
With over 20 years experience, Dr. Dambacher specializes in molecular, chemical and synthetic biology. He conducts research to better pharmaceuticals and oversees the daily operations of the company. Dr. Dambacher is responsible for liaising with clients to help them get over technical hurdles, start up new labs and to solve their computational needs in the genomics and multi-omics space. He is currently also at the Cancer Early Detection Advanced Research Center in the Knight Cancer Institute at Oregon Health and Science University in Portland, Oregon. |
| Geographic Area of Distribution: |
International |
| Affiliations: |
Phi Kappa Phi Honor Society; A.A.A.S. |
| University/Degree: |
BA, Cell/Cellular and Molecular Biology, University of Hawaii, Hilo, 2001; M.S., Cell and Molecular Biology, San Diego State University, 2006; Ph.D., Chemistry and Biology, The Scripps Research Institute, 2011 |
| Born: |
May 16, 1979, Sonora, California |
| Hobbies/Sports: |
Coaching wrestling and football, camping, hiking, fishing |
| Work History: |
Previously, Dr. Dambacher served as the Director of Biochemistry at Singular Genomics, a Senior Scientist-Group Lead at Omniome, Inc. and a Scientist-Assay Development at Prognosys Biosciences. He completed a postdoctoral fellowship in CryoEM at The Scripps Research Institute from 2013 to 2015. |
| Honors & Awards: |
Student Research Achievement Award, Biophysical Society, 2006; Scripps Society of Fellows Travel Award; numerous fellowships |
| Published Works: |
Numerous Peer-Reviewed Scientific Publications; Several Patents |
| Career Accomplishments: |
Dr. Dambacher completed a Postdoctoral Fellowship in CryoEM at the Scripps Research Institute from 2013 thru 2015. |
